Nabi (NABI) To Bring in Russell Plumb as President and CEO Post-Merger
Tweet Send to a FriendGet Alerts NABI Hot Sheet
Price: $1.80 --0%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 61.6%
Revenue Growth %: -42.5%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 61.6%
Revenue Growth %: -42.5%
Trade NABI Now!
Nabi Biopharmaceuticals (Nasdaq: NABI) today announced that Biota Holdings Limited has entered into advanced discussions with Russell H. Plumb, the former President and Chief Executive Officer of Inhibitex, Inc., with a view to agreeing on the terms and conditions for the appointment of Mr. Plumb as the President and Chief Executive Officer of Biota Pharmaceuticals, Inc., the combined company upon the successful completion of the proposed business combination transaction between Biota and Nabi. It is also expected that Mr. Plumb will be appointed as a director of Biota Pharmaceuticals, Inc.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- JPMorgan (JPM) Shareholders Support Dimon in Dual Role
- Zale (ZLC) Names Terry Burman as Chairman
- Gentex (GNTX) CFO Dykman Resigns
Create E-mail Alert Related Categories
Management ChangesLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

